“We are pleased to continue the Endpoints to Insights educational series throughout 2016 and to deliver programs that provide valuable information to pharmaceutical and biotech researchers,” said Scott Dixon, Vice President, Marketing, ERT
January 26, 2016 (PRWEB) January 26, 2016 -- ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced that it will continue its Endpoints to Insights Educational Series throughout 2016. The series enables pharmaceutical researchers to participate in interactive programs in which ERT scientists and partner subject matter experts share their knowledge in optimizing the electronic collection of endpoint data and delivering real time business intelligence and analytics across clinical studies and programs.
Each month, the ERT Endpoints to Insights Webinar Series will focus on different aspects of effective endpoint data collection and on demand analytics for clinical trials and healthcare. The current schedule of webinars includes:
- January 27, 2016: Intelligent Trial Management: Achieving a Data Driven Paradigm in Clinical Trials Management
- February 11, 2016: New ICH E14 Update: An Alternative to the Thorough QT Trial Gets Regulatory Approval
- February 16, 2016: Insights Cloud enables Analytics-Driven Trial Management across Multiple Programs
- February 17, 2016: Effective Use of Electronic COAs, Rater Training & Rater Surveillance in Respiratory Clinical Studies
“We are pleased to continue the Endpoints to Insights educational series throughout 2016 and to deliver programs that provide valuable information to pharmaceutical and biotech researchers,” said Scott Dixon, Vice President, Marketing, ERT. “We had great response to last year’s installments, which were well received by busy researchers looking for a convenient means to stay abreast of industry advances to help them meet immediate and long-term development goals.”
For additional information and to register for any upcoming webinars, please visit: https://www.ert.com/upcoming-webinars/. Access to recently recorded webinars can be found at https://www.ert.com/past-webinars/.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.
ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.